Pharvaris N.V.
PHVS
$14.00
$0.282.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.81M | 13.32M | 12.18M | 10.64M | 9.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.07M | 41.67M | 37.01M | 30.73M | 29.26M |
| Operating Income | -48.07M | -41.67M | -37.01M | -30.73M | -29.26M |
| Income Before Tax | -35.73M | -45.60M | -31.92M | -30.11M | -34.45M |
| Income Tax Expenses | 1.32M | 253.00K | 76.00K | 309.50K | 805.00K |
| Earnings from Continuing Operations | -37.05M | -45.86M | -32.00M | -30.42M | -35.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.05M | -45.86M | -32.00M | -30.42M | -35.26M |
| EBIT | -48.07M | -41.67M | -37.01M | -30.73M | -29.26M |
| EBITDA | -48.03M | -41.65M | -36.99M | -30.72M | -29.24M |
| EPS Basic | -0.68 | -0.85 | -0.59 | -0.57 | -0.80 |
| Normalized Basic EPS | -0.41 | -0.53 | -0.37 | -0.35 | -0.49 |
| EPS Diluted | -0.68 | -0.85 | -0.59 | -0.57 | -0.80 |
| Normalized Diluted EPS | -0.41 | -0.53 | -0.37 | -0.35 | -0.49 |
| Average Basic Shares Outstanding | 54.32M | 54.07M | 53.94M | 53.75M | 44.20M |
| Average Diluted Shares Outstanding | 54.32M | 54.07M | 53.94M | 53.75M | 44.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |